Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rituximab and Chemotherapy for Newly Diagnosed Follicular Lymphoma: Real-World Report of Polish Lymphoma Research Group.
Paszkiewicz-Kozik E, Debowska M, Jakacka N, Kotarska M, Szymanski M, Wisniewski K, Konska A, Jarzembowska M, Drozd-Sokolowska J, Romejko-Jarosinska J, Szumera-Cieckiewicz A, Rymkiewicz G, Ziarkiewicz-Wroblewska B, Lech-Maranda E, Walewski J, Hus I. Paszkiewicz-Kozik E, et al. Among authors: hus i. Chemotherapy. 2022;67(4):201-210. doi: 10.1159/000523921. Epub 2022 Mar 4. Chemotherapy. 2022. PMID: 35249035
Bendamustine as monotherapy and in combination regimens for the treatment of chronic lymphocytic leukemia and non-hodgkin lymphoma: a retrospective analysis.
Hus I, Jawniak D, Gorska-Kosicka M, Butrym A, Dzietczenia J, Wrobel T, Grzegorz M, Lech-Maranda E, Warzocha K, Waszczuk-Gajda A, Jedrzejczak WW, Krawczyk-Kulis M, Kyrcz-Krzemien S, Poplawska L, Walewski J, Dmoszynska A. Hus I, et al. Chemotherapy. 2013;59(4):280-9. doi: 10.1159/000357468. Epub 2014 Jan 21. Chemotherapy. 2013. PMID: 24457828
Real‑life experience with bortezomib‑based regimens in elderly patients with newly diagnosed multiple myeloma and comorbidities: a Polish retrospective multicenter study.
Hus I, Walter-Croneck A, Masternak A, Jurczyszyn A, Usnarska-Zubkiewicz L, Bołkun Ł, Druzd-Sitek A, Rymko M, Łętowska J, Lech-Marańda E, Pasiarski M, Dmoszyńska A. Hus I, et al. Pol Arch Intern Med. 2017 Nov 30;127(11):765-774. doi: 10.20452/pamw.4099. Epub 2017 Sep 14. Pol Arch Intern Med. 2017. PMID: 28906482 Free article.
Pixantrone, etoposide, bendamustine, rituximab (P[R]EBEN) as an effective salvage regimen for relapsed/refractory aggressive non-Hodgkin lymphoma-Polish Lymphoma Research Group real-life analysis.
Długosz-Danecka M, Hus I, Puła B, Jurczyszyn A, Chojnacki T, Blajer-Olszewska B, Drozd-Sokołowska J, Raźny M, Romejko-Jarosińska J, Taszner M, Jurczak W. Długosz-Danecka M, et al. Among authors: hus i. Pharmacol Rep. 2019 Jun;71(3):473-477. doi: 10.1016/j.pharep.2019.02.001. Epub 2019 Feb 6. Pharmacol Rep. 2019. PMID: 31003160
Hodgkin lymphoma transformation of chronic lymphocytic leukemia-A real life data from the Polish Lymphoma Research Group.
Drozd-Sokołowska J, Zaucha JM, Żółtak T, Jamroziak K, Grzybowska-Izydorczyk O, Witkowska M, Waszczuk-Gajda A, Kaźmierczak M, Szczepaniak A, Subocz E, Knopińska-Posłuszny W, Hołojda J, Kopińska A, Hus I, Rybka J, Wołowiec D, Kwiatkowski J, Hałaburda K, Smolewski P, Giebel S, Wiktor-Jędrzejczak W. Drozd-Sokołowska J, et al. Among authors: hus i. Hematol Oncol. 2019 Oct;37(4):383-391. doi: 10.1002/hon.2624. Epub 2019 Jun 14. Hematol Oncol. 2019. PMID: 31026087
Safety and Efficacy of Bendamustine Monotherapy in the First-Line Treatment of Patients with Chronic Lymphocytic Leukemia: Polish Lymphoma Research Group Real-Life Analysis.
Wołowiec D, Szymczyk A, Potoczek S, Krochmalczyk D, Zawirska D, Piotrowska M, Malenda A, Soroka-Wojtaszko M, Kopacz A, Wąsik-Szczepanek E, Graboś-Michalak J, Raźny M, Wichary R, Bramowicz-Jarosz B, Seweryn M, Długosz-Danecka M, Hus I. Wołowiec D, et al. Among authors: hus i. Chemotherapy. 2019;64(3):155-162. doi: 10.1159/000503220. Epub 2019 Nov 12. Chemotherapy. 2019. PMID: 31715597
Salvage autologous hematopoietic stem cell transplantation for multiple myeloma performed with stem cells procured after previous high dose therapy - a multicenter report by the Polish Myeloma Study Group.
Drozd-Sokołowska J, Waszczuk-Gajda A, Biecek P, Kobylińska K, Mańko J, Hus I, Szmigielska-Kapłon A, Nowicki M, Romejko-Jarosińska J, Kozioł M, Sędzimirska M, Sachs W, Mądry K, Boguradzki P, Król M, Hus M, Basak G, Dwilewicz-Trojaczek J. Drozd-Sokołowska J, et al. Among authors: hus m, hus i. Leuk Lymphoma. 2021 Dec;62(13):3226-3234. doi: 10.1080/10428194.2021.1950712. Epub 2021 Aug 16. Leuk Lymphoma. 2021. PMID: 34396931
Outcome of SARS-CoV-2-Infected Polish Patients with Chronic Lymphocytic Leukemia.
Puła B, Pruszczyk K, Pietrusza E, Morawska M, Piszczek W, Kalicińska E, Szeremet A, Tryc-Szponder J, Wąsik-Szczepanek E, Drozd-Sokołowska J, Krzemień H, Rejus A, Gajewska M, Wiśniewski K, Wysocki M, Majeranowski A, Paszkiewicz-Kozik E, Steckiewicz P, Szukalski Ł, Bołkun Ł, Długosz-Danecka M, Giannopoulos K, Jamroziak K, Lech-Marańda E, Hus I. Puła B, et al. Among authors: hus i. Cancers (Basel). 2022 Jan 22;14(3):558. doi: 10.3390/cancers14030558. Cancers (Basel). 2022. PMID: 35158826 Free PMC article.
Early efficacy and safety of obinutuzumab with chemotherapy in previously untreated patients with follicular lymphoma: A real-world retrospective report of the Polish Lymphoma Research Group.
Paszkiewicz-Kozik E, Hus I, Palka M, Dębowska M, Końska A, Kotarska M, Tyczyńska A, Joks M, Twardosz M, Giza A, Wąsik-Szczepanek E, Kalicińska E, Wiśniewska A, Morawska M, Lewicka B, Szymański M, Targoński Ł, Romejko-Jarosińska J, Drozd-Sokołowska J, Subocz E, Swoboda R, Długosz-Danecka M, Lech-Maranda E, Walewski J. Paszkiewicz-Kozik E, et al. Among authors: hus i. Adv Clin Exp Med. 2023 Jan;32(1):131-136. doi: 10.17219/acem/157290. Adv Clin Exp Med. 2023. PMID: 36603138 Free article.
Molnupiravir is effective in patients with haematological malignancies.
Bołkun Ł, Pula B, Kołkowska-Leśniak A, Morawska M, Cichocka E, Charlinski G, Garus B, Giebel S, Piszcz J, Drozd-Sokolowska J, Kwiatkowski J, Biernat M, Hus I, Lech-Maranda E, Długosz-Danecka M, Giannopoulos K, Wróbel T. Bołkun Ł, et al. Among authors: hus i. Int J Cancer. 2023 Sep 15;153(6):1251-1256. doi: 10.1002/ijc.34442. Epub 2023 Feb 7. Int J Cancer. 2023. PMID: 36691818
82 results